Minnetonka, MN · Founded 2013 · Privately Held (backing)
Developer of artificial intelligence (AI) diagnostic tools designed to improve the detection and management of cardiovascular disease. Angioinsight is based in Minnetonka, MN and was founded in 2013. It is valued at about $18 million as of Oct 2026, set by institutional fund marks. It has raised $10.5 million.
PMV mark · valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$10.5M
Last round
—
Team — not yet on record
No current team members for Angioinsight are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Angioinsight with a free account
·Watch Angioinsight: the Monday email on marks, rounds and moves
